DGAP-News: MEDISANA continues strong revenue growth and achieves the result targeted through expansion abroad
(firmenpresse) - Medisana AG / Half Year Results
31.08.2010 15:55
Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
MEDISANA continues strong revenue growth and achieves the result targeted
through expansion abroad
- Revenue gains of 47% to EUR 21.2 million
- Positive outlook for the second half-year
- Target for 2010: revenue growth from EUR 36.6 million to over EUR 50
million.
Hilden, August 31, 2010 - MEDISANA AG (Sec. No.: 549254) generated revenue
of EUR 21.2 million in the first half-year 2010 with a 47% growth rate and
has thus continued its record performance. In addition to its own
successful sales drive, the first-time consolidation of the new foreign
subsidiaries, Gimelli Laboratories Inc. and Royal Appliance España S.L.,
also contributed to the further strengthening of the company's competitive
position. The positive trend in other European countries continued with
revenue of EUR 7.4 million (previous year: EUR 6.2 million), while revenue
of EUR 3.4 million (previous year: EUR 0.8 million) was generated outside
of Europe. In Germany, the revenue of the Hilden-based home health care
specialist rose from EUR 7.5 million in the previous year to EUR 10.4
million.
With sustained strong order intake, the rapid integration of the new
foreign subsidiaries will have a significantly greater impact over the
coming months. Even so, MEDISANA is set to achieve revenue of around EUR 30
million in the current half-year and annual revenue of over EUR 50 million.
The Management Board also anticipates strong operating earnings (EBIT) for
the period July to December 2010. In the first half-year, the consolidation
of the subsidiaries in Hong Kong/China and Spain as well as various special
factors had a noticeable impact on the profit and loss statement, resulting
in EBIT of EUR -0.7 million (previous year: EUR 0.1 million). With a
slightly increased balance sheet total of EUR 39.8 million, the equity
ratio stood at 34% as at June 30, 2010, with MEDISANA's balance-sheet
structures remaining in good health.
The major changes as part of internationalization have primarily resulted
in an increase in headcount. The MESDISANA group employed 69 staff as at
June 30, 2009, whereas this figure rose sharply to 596 by mid-2010.
According to the Management Board, there may even be a further increase
shortly as additional personnel are required for new orders as part of the
ramp-up of in-house production at Gimelli. In-house production is one of
MEDISANA's stated objectives to achieve a positive impact on earnings
performance by significantly increasing value creation.
In the light of sustained strong order intake and highly promising product
launches at the start of the IFA trade fair on September 3, the Management
Board anticipates an improved result for the 2010 business year, with
revenue exceeding EUR 50 million, and foresees further growth in 2011.
Forthcoming dates
IFA (trade fair), Berlin September 3-8, 2010
Analysts and investors conference, Hamburg September 23, 2010
Report on 3rd quarter 2010 November 29, 2010
The full half-year financial report as at June 30, 2010 can be found on the
company's website under InvestorRelations/Financial Reports.
MEDISANA AG
Itterpark 7-9, 40724 Hilden
Tel.: +49 (0) 2103-200 7-60
Fax: +49 (0) 2103-200 7-10
info(at)medisana.de
www.medisana.de
UBJ. GmbH
Kapstadtring 10, 22297 Hamburg
Ingo Janssen
Tel.: +49 (0) 40 6378 5410
Fax.: +49 (0) 40 6378 5423
ir(at)ubj.de
www.ubj.de
31.08.2010 15:55 Ad hoc announcement, Financial News and Press Release distributed by DGAP. Medienarchiv atwww.dgap-medientreff.deandwww.dgap.de---------------------------------------------------------------------------
Language: English
Company: Medisana AG
Itterpark 7 - 9
40724 Hilden
Deutschland
Phone: +49 (0)2103 2007-60
Fax: +49 (0)2103 2007-75
E-mail: info(at)medisana.de
Internet: www.medisana.de
ISIN: DE0005492540
WKN: 549254
Listed: Regulierter Markt in Frankfurt (General Standard);
Freiverkehr in Hamburg, München, Berlin, Düsseldorf,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------------
Datum: 31.08.2010 - 15:55 Uhr
Sprache: Deutsch
News-ID 32122
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 249 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MEDISANA continues strong revenue growth and achieves the result targeted through expansion abroad"
steht unter der journalistisch-redaktionellen Verantwortung von
Medisana AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
